Edinburgh Research Explorer

The importance of clinician, patient & researcher collaborations in Alport Syndrome

Research output: Contribution to journalArticle

  • Michelle N Rheault
  • Judith Savige
  • Michael J Randles
  • Andre Weinstock
  • Melissa Stepney
  • Neil Turner
  • Gina Parziale
  • Oliver Gross

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

    Final published version, 2 MB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

https://link.springer.com/article/10.1007%2Fs00467-019-04241-7
Original languageEnglish
JournalPediatric Nephrology
Early online date1 May 2019
DOIs
Publication statusE-pub ahead of print - 1 May 2019

Abstract

Alport syndrome (AS) is caused by mutations in the genes COL4A3, COL4A4 or COL4A5 and is characterised by progressive glomerular disease, sensorineural hearing loss and ocular defects. Occurring in less than 1:5000, AS is rare genetic disorder but still accounts for >1% of the prevalent population receiving renal replacement therapy. There is also increasing awareness about the risk of chronic kidney disease in individuals with heterozygous mutations in AS genes. The mainstay of current therapy is the use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers, yet potential new therapies are now entering clinical trials. The 2017 International Workshop on Alport Syndrome in Glasgow was a preconference workshop ahead of the 50th anniversary meeting of the European Society for Pediatric Nephrology. It focussed on updates in clinical practice, genetics, basic science and also incorporated patient perspectives. More than 80 international experts including clinicians, geneticists, researchers from academia and industry, and patient representatives took part in panel discussions and breakout groups. This report summarises the workshop proceedings and the relevant contemporary literature. It highlights the unique clinician, patient and researcher collaborations achieved by regular engagement between the groups.

Download statistics

No data available

ID: 82012024